Purpose: Triple-negative breast cancer (TNBC) is an aggressive subtype with poor outcomes. Antibody-drug conjugates (ADCs), linking monoclonal antibodies to cytotoxic payloads, show promise as targeted therapies. Despite growing ... ...

请注册登录后继续浏览